Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-26 @ 12:32 AM
NCT ID: NCT01783860
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT01783860
Study Brief: Oral Azithromycin Versus Doxycycline in Posterior Blepharitis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Doxycycline Oral doxycycline 100mg capsule every 12 hours for one month Doxycycline : None None 12 50 0 50 View
Oral Azithromycin Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days. Azithromycin : None None 3 50 0 50 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
vomiting and loss of appetide NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Other Events(If Any):